The website of Pathology In Practice Magazine

Genes associated with high risk of severe COVID-19

Scientists from PrecisionLife have found 68 genes associated with risk of developing severe COVID-19 by using its proprietary AI-enabled precision medicine platform to analyse the genomes of 929 patients who had a severe response to SARS-CoV-2.

Prior to an effective and widely available vaccine, PrecisionLife’s insights may help to identify patients who are at greatest risk of developing the most severe forms of COVID-19. They can inform the development of biomarker-driven tests, targeted shielding and new therapeutic strategies, with the aim of identifying high-risk people, reducing disease burden and improving survival rates.

Established genome-wide association studies (GWAS) approaches have been limited by the heterogeneous nature of COVID-19, making it difficult to explain the wide range of symptoms and impacts of predisposing co-morbidities associated with the disease. The study has overcome this barrier by evaluating combinations of genetic features, which is not possible with existing GWAS approaches.

Using a combinatorial (high-order epistasis) analysis approach, PrecisionLife identified 68 protein-coding genes that were highly associated with severe COVID-19, nine of which have been previously linked to differential response to SARS-CoV-2. These 68 genes include several protein targets and pathways, nine of which are targeted by drugs that have reached at least phase I clinical trials.

The graphic represents the disease architecture of the severe COVID-19 patient population generated by the PrecisionLife platform. Each circle represents a disease-associated SNP genotype in patients, and colours represent distinct patient subpopulations.

www.precisionlife.com

Upcoming Events

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 22/06/2021 16:08:48 Step Communications Ltd. Registered in England. Registration Number 3893025